Trial intelligence / Profile preview

Esomeprazole vs lansoprazole in erosive esophagitis (China)

CTR20160792Phase 3Suspended

Sponsor
Takeda
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of esomeprazole in erosive esophagitis (EE), sponsored by Takeda. Started Nov 2016; status: suspended.

02

Drugs

esomeprazole
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on CTR20160792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call